3M Company
NYSE:MMMConglomerates
+$1.72 today
- Market cap
- $93.55B
- Beta
- 1.09
- P/E (TTM)
- 30.6
- EPS (TTM)
- $5.27
- Dividend yield
- 1.88%
Volume 3.20M
Average 3.83M
MMM Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
3M CompanyNYSE: MMM
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development grows, but more slowly than its trailing trend
Q3 FY2026 research & development of $304M rose 2.4% year over year, behind the +5.4% change in trailing-twelve-month research & development. Sequentially, it rose 0.7% from the prior quarter. Over 3 fiscal years it compounded at -14.3% a year.
Context
- Research & development amounted to 4.7% of revenue in FY2025, up 0.3 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +2.4% toward the trailing-twelve-month pace of +5.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 1.17B USD
- Year-over-year change
- +9.3%
- 4-year CAGR
- -12.3%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.17B | +9.3% |
| FY2024 | 2024-12-31 | 1.07B | -4.7% |
| FY2023 | 2023-12-31 | 1.12B | -39.5% |
| FY2022 | 2022-12-31 | 1.86B | -6.1% |
| FY2021 | 2021-12-31 | 1.98B | — |
Research & Development vs competitors
How MMM compares with its peers on the latest reported figures
- MMM's LTM Sep 2026 research & development of $1.21B is the 2nd highest of the 10 companies compared; the peer median is $80M.
- Its year-over-year change of +5.4% is the 3rd highest of 8, against a peer median of -2.5%.
- Research & development amounts to 4.8% of revenue for MMM, versus a peer median of 3.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.65B | -10.5% | +7.0% | 5.4% | |
| LTM Sep 2026 | $1.21B | +5.4% | -14.3% | 4.8% | |
| LTM Jun 2026 | $1.14B | +2.3% | +2.0% | 6.7% | |
| LTM Jun 2026 | $726M | -5.7% | -1.2% | 8.7% | |
| LTM Jun 2026 | $676M | -2.5% | — | 4.1% | |
| LTM Sep 2026 | $80M | +23.8% | +11.5% | 2.3% | |
| LTM Sep 2026 | $71.63M | +8.5% | +4.7% | 3.6% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MMM) | $80M | -2.5% | +4.7% | 3.6% | |
Competitors are the stored peer set for MMM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 35.36B | 34.23B | 24.61B | 24.58B | 24.95B |
| Cost of Revenue | 18.74B | 19.26B | 15.04B | 14.5B | 15.08B |
| Gross Profit | 16.61B | 14.97B | 9.57B | 10.08B | 9.87B |
| Gross Margin | 47.0% | 43.7% | 38.9% | 41.0% | 39.6% |
| Research & Development | 1.98B | 1.86B | 1.12B | 1.07B | 1.17B |
| Selling, General & Admin | 7.11B | 9.04B | 4.4B | 4.08B | 3.98B |
| Operating Expenses | 9.09B | 10.89B | 5.53B | 5.15B | 5.31B |
| Depreciation & Amortization | 1.92B | 1.83B | 1.43B | 1.22B | 1.31B |
| EBITDA | 9.58B | 8.72B | (8.91B) | 7.23B | 6.28B |
| EBITDA Margin | 27.1% | 25.5% | -36.2% | 29.4% | 25.2% |
| Operating Income | 7.53B | 4.07B | 4.05B | 4.93B | 4.56B |
| Operating Margin | 21.3% | 11.9% | 16.4% | 20.1% | 18.3% |
| Interest Income | 26M | 67M | 250M | 452M | 175M |
| Interest Expense | 457M | 498M | 932M | 1.18B | 720M |
| Other Income / Expenses | (312M) | 2.33B | (15.3B) | (103M) | (350M) |
| Income Before Tax | 7.21B | 6.4B | (11.25B) | 4.83B | 4.21B |
| Pre-Tax Margin | 20.4% | 18.7% | -45.7% | 19.6% | 16.9% |
| Income Tax Expense | 1.29B | 612M | (2.87B) | 804M | 1B |
| Net Income | 5.92B | 5.78B | (7B) | 4.17B | 3.25B |
| Net Margin | 16.7% | 16.9% | -28.4% | 17.0% | 13.0% |
| EPS (Basic) | 10.23 | 10.21 | (12.63) | 7.58 | 6.04 |
| EPS (Diluted) | 10.12 | 10.18 | (12.63) | 7.55 | 6.00 |
| Weighted Avg Shares | 579M | 566M | 553.9M | 550.8M | 534.3M |
| Weighted Avg Shares (Diluted) | 585.3M | 567.6M | 553.9M | 552.4M | 539M |
3M Company
NYSE:MMM
Intrinsic Alpha fair value
Locked
Current Price
$181.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.